Use of hydrophobic crosslinking agents to prepare crosslinked biomaterial compositions
View Patent ↗The present invention discloses novel crosslinked biomaterial compositions which are prepared using hydrophobic polymers as a crosslinking agent. Preferred hydrophobic polymers are those that contain two or more reactive succinimidyl groups, including disuccinimidyl suberate, bis(sulfosuccinimidyl)suberate, and dithiobis(succinimidyl)propionate. Crosslinked biomaterial compositions prepared using mixtures of hydrophobic and hydrophilic crosslinking agents are also disclosed. The compositions of the present invention can be used to prepare formed implants for use in a variety of medical applications.
1. A method for preparing a crosslinkable composition that crosslinks in situ following administration to a patient to form a heterogeneous, crosslinked biomaterial composition, comprising:
an aqueous suspension of a biomaterial comprised of a biocompatible polymer containing nucleophilic groups; and
a dry mixture of a hydrophilic crosslinking agent and a hydrophobic crosslinking agent containing up to about 14 carbon atoms and comprising a polyacid esterified with reactive moieties selected from succinimidyl groups and sulfosuccinimidyl groups, wherein the hydrophilic crosslinking agent and the hydrophobic crosslinking agent are each capable of covalently crosslinking the biomaterial but are not reactive with respect to each other.
2. The method of claim 1 , wherein the biomaterial is selected from collagens, glycosaminoglycans, and mixtures thereof.
3. The method of claim 2 , wherein the biomaterial is a collagen.
4. The method of claim 3 , wherein the collagen is fibrillar collagen.
5. The method of claim 3 , wherein the collagen is nonfibrillar collagen.
6. The method of claim 5 , wherein the nonfibrillar collagen is a chemically derivatized collagen selected from succinylated collagen and methylated collagen.
7. The method of claim 3 , wherein the collagen is selected from Type I collagen, Type II collagen, Type III collagen, Type IV collagen, and mixtures thereof.
8. The method of claim 3 , wherein the collagen is telopeptide collagen.
9. The method of claim 3 , wherein the collagen is atelopeptide collagen.
10. The method of claim 3 , wherein the collagen is denatured collagen.
11. The method of claim 2 , wherein the biomaterial is a glycosaminoglycan.
12. The method of claim 11 , wherein the glycosaminoglycan is selected from hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, keratin sulfate, keratosulfate, chitin, chitosan, heparin, and derivatives thereof.
13. The method of claim 1 , wherein the nucleophilic groups are primary amino groups.
14. The method of claim 1 , wherein the polyacid is selected from trimethylolpropane tricarboxylic acid, di(trimethylol propane) tetracarboxylic acid, heptanedioic acid, suberic acid, and hexadecanedioic acid.
15. The method of claim 1 , wherein the hydrophobic crosslinking agent has two, three, or four carboxylic acid groups each esterified with a succinimidyl group.
16. The method of claim 1 , wherein the hydrophobic crosslinking agent has two, three, or four carboxylic acid groups each esterified with a sulfosuccinimidyl group.
17. The method of claim 1 , wherein the hydrophobic crosslinking agent is selected from disuccinimidyl suberate, dithiobis(succinimidylpropionate, bis(sulfosuccinimidyl) suberate, bis(2-succinimidooxycarbonyloxy)ethyl sulfone, and 3,3-dithiobis(sulfosuccinimidylpropionate).
18. The method of claim 17 , wherein the hydrophobic crosslinking agent is disuccinimidyl suberate.
19. The method of claim 1 , wherein the hydrophilic crosslinking agent comprises an activated hydrophilic polymer.
20. The method of claim 19 , wherein the activated hydrophilic polymer is selected from polyethylene glycol succinimidyl glutarate, polyethylene glycol succinimidyl, polyethylene glycol succinimidyl succinamide, and polyethylene glycol succinimidyl carbonate.
21. The method of claim 20 , wherein the activated hydrophilic polymer is polyethylene glycol succinimidyl glutarate.
22. The method of claim 20 , wherein the activated hydrophilic polymer is polyethylene glycol succinimidyl.